NEU 3.32% $20.52 neuren pharmaceuticals limited

Ann: Investor Presentation, 14 March 2023, page-12

  1. 2,565 Posts.
    lightbulb Created with Sketch. 394
    Agree - I think this approval will open the doors for other indications - I didn't realise Acadia had all rights for all indications - I thought it was just Rett and Fragile X
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.